CIM Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $519K | Sell |
2,830
-14
| -0.5% | -$2.58K | 0.14% | 127 |
|
|
2025
Q4 | $501K | Hold |
2,844
| – | – | 0.13% | 128 |
|
|
2025
Q3 | $398K | Sell |
2,844
-2,920
| -51% | -$395K | 0.11% | 148 |
|
|
2025
Q2 | $803K | Buy |
5,764
+2,877
| +100% | +$358K | 0.15% | 127 |
|
|
2025
Q1 | $395K | Sell |
2,887
-3
| -0.1% | -$429 | 0.09% | 138 |
|
|
2024
Q4 | $442K | Buy |
2,890
+13
| +0.5% | +$2.19K | 0.13% | 130 |
|
|
2024
Q3 | $558K | Sell |
2,877
-52
| -2% | -$10.9K | 0.16% | 111 |
|
|
2024
Q2 | $679K | Sell |
2,929
-17
| -0.6% | -$3.69K | 0.21% | 93 |
|
|
2024
Q1 | $635K | Hold |
2,946
| – | – | 0.19% | 109 |
|
|
2023
Q4 | $762K | Sell |
2,946
-130
| -4% | -$31.9K | 0.25% | 81 |
|
|
2023
Q3 | $791K | Sell |
3,076
-72
| -2% | -$19.3K | 0.29% | 74 |
|
|
2023
Q2 | $897K | Buy |
3,148
+22
| +0.7% | +$6.55K | 0.31% | 67 |
|
|
2023
Q1 | $869K | Buy |
3,126
+147
| +5% | +$40.7K | 0.32% | 63 |
|
|
2022
Q4 | $825K | Sell |
2,979
-1,612
| -35% | -$455K | 0.32% | 58 |
|
|
2022
Q3 | $1.23M | Hold |
4,591
| – | – | 0.54% | 27 |
|
|
2022
Q2 | $936K | Sell |
4,591
-24
| -0.5% | -$4.91K | 0.39% | 44 |
|
|
2022
Q1 | $972K | Sell |
4,615
-5
| -0.1% | -$1.09K | 0.33% | 64 |
|
|
2021
Q4 | $1.11M | Buy |
4,620
+611
| +15% | +$157K | 0.33% | 49 |
|
|
2021
Q3 | $1.14M | Buy |
4,009
+1,286
| +47% | +$421K | 0.36% | 48 |
|
|
2021
Q2 | $943K | Sell |
2,723
-62
| -2% | -$18.8K | 0.29% | 68 |
|
|
2021
Q1 | $779K | Sell |
2,785
-2,993
| -52% | -$807K | 0.25% | 76 |
|
|
2020
Q4 | $1.42M | Buy |
5,778
+4,372
| +311% | +$1.13M | 0.46% | 36 |
|
|
2020
Q3 | $399K | Sell |
1,406
-13
| -0.9% | -$3.63K | 0.15% | 130 |
|
|
2020
Q2 | $380K | Hold |
1,419
| – | – | 0.15% | 132 |
|
|
2020
Q1 | $449K | Buy |
1,419
+43
| +3% | +$13K | 0.22% | 100 |
|
|
2019
Q4 | $408K | Hold |
1,376
| – | – | 0.16% | 134 |
|
|
2019
Q3 | $320K | Sell |
1,376
-140
| -9% | -$32.6K | 0.12% | 212 |
|
|
2019
Q2 | $355K | Buy |
1,516
+65
| +4% | +$15K | 0.13% | 195 |
|
|
2019
Q1 | $343K | Sell |
1,451
-1,461
| -50% | -$460K | 0.13% | 207 |
|
|
2018
Q4 | $876K | Buy |
2,912
+1,461
| +101% | +$466K | 0.38% | 40 |
|
|
2018
Q3 | $513K | Hold |
1,451
| – | – | 0.18% | 146 |
|
|
2018
Q2 | $421K | Sell |
1,451
-37
| -2% | -$10.4K | 0.15% | 196 |
|
|
2018
Q1 | $407K | Sell |
1,488
-34
| -2% | -$10.6K | 0.14% | 207 |
|
|
2017
Q4 | $485K | Sell |
1,522
-22
| -1% | -$7.06K | 0.17% | 176 |
|
|
2017
Q3 | $483K | Sell |
1,544
-1,767
| -53% | -$523K | 0.18% | 167 |
|
|
2017
Q2 | $898K | Sell |
3,311
-47
| -1% | -$12.4K | 0.32% | 66 |
|
|
2017
Q1 | $918K | Sell |
3,358
-304
| -8% | -$86K | 0.32% | 69 |
|
|
2016
Q4 | $1.04M | Buy |
3,662
+54
| +1% | +$16K | 0.38% | 49 |
|
|
2016
Q3 | $1.13M | Sell |
3,608
-260
| -7% | -$77K | 0.43% | 40 |
|
|
2016
Q2 | $935K | Buy |
3,868
+1,717
| +80% | +$453K | 0.39% | 63 |
|
|
2016
Q1 | $560K | Sell |
2,151
-215
| -9% | -$56.8K | 0.24% | 122 |
|
|
2015
Q4 | $725K | Hold |
2,366
| – | – | 0.33% | 108 |
|
|
2015
Q3 | $690K | Buy |
2,366
+62
| +3% | +$20.5K | 0.33% | 113 |
|
|
2015
Q2 | $931K | Sell |
2,304
-13
| -0.6% | -$5.22K | 0.41% | 84 |
|
|
2015
Q1 | $978K | Hold |
2,317
| – | – | 0.42% | 83 |
|
|
2014
Q4 | $787K | Sell |
2,317
-2,181
| -48% | -$706K | 0.36% | 104 |
|
|
2014
Q3 | $1.49M | Sell |
4,498
-276
| -6% | -$91K | 0.76% | 29 |
|
|
2014
Q2 | $1.5M | Sell |
4,774
-138
| -3% | -$41.5K | 0.76% | 30 |
|
|
2014
Q1 | $1.5M | Sell |
4,912
-149
| -3% | -$47.3K | 0.69% | 30 |
|
|
2013
Q4 | $1.42M | Buy |
5,061
+250
| +5% | +$64.7K | 0.72% | 41 |
|
|
2013
Q3 | $1.16M | Hold |
4,811
| – | – | 0.69% | 50 |
|
|
2013
Q2 | $1.03M | Buy |
+4,811
| New | +$1.03M | 0.61% | 57 |
|
Other funds holding BIIB
CIM Investment Management's BIIB Position: Q1 2026 in Review
CIM Investment Management reduced its Biogen (BIIB) stake by 0.49% in Q1 2026, selling an estimated $2.58K and leaving 2,830 shares worth $519K. The position accounts for 0.14% of the portfolio, ranked #127.
CIM Investment Management first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.5M in Q2 2014. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- CIM Investment Management held 2,830 shares of Biogen worth $519K as of Q1 2026.
- CIM Investment Management sold 14 Biogen shares in Q1 2026, an estimated $2.58K.
- Biogen made up 0.14% of CIM Investment Management's portfolio in Q1 2026, its #127 holding.
- CIM Investment Management first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- CIM Investment Management's Biogen position peaked at $1.5M in Q2 2014.
- 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.